Prolotherapy

Prolotherapy — short for proliferative therapy — is a minimally invasive injection-based treatment used by some practitioners to address chronic musculoskeletal pain, joint instability, and connective tissue concerns. The approach involves injecting a solution, most commonly a dextrose (sugar water) mixture, into areas of perceived structural weakness such as tendons, ligaments, and joint spaces. The goal, as understood by practitioners, is to stimulate the body's own healing response in tissues that may have become chronically painful due to incomplete recovery from injury or overuse.

Prolotherapy sits within the broader landscape of regenerative and injection-based therapies, which also includes platelet-rich plasma (PRP) and stem cell treatments. Unlike corticosteroid injections, which are primarily aimed at reducing inflammation, prolotherapy is theorized to work by initiating a localized, controlled inflammatory response that may encourage tissue repair. Some practitioners view it as a way to address the root structural cause of pain rather than simply managing symptoms.

The practice attracts individuals who feel they have not found adequate relief through conventional treatments such as physical therapy, anti-inflammatory medications, or surgery. It is often sought for conditions involving ligament laxity, tendon degeneration, or persistent joint discomfort. Prolotherapy is typically administered by physicians, osteopathic doctors, or other licensed medical professionals with specialized training. While interest in the modality has grown in integrative and sports medicine circles, it remains categorized as a complementary approach, and prospective patients are encouraged to discuss it carefully with a qualified healthcare provider before proceeding.

The roots of prolotherapy can be traced back to the early twentieth century, when physicians began experimenting with injection-based techniques to address joint pain and instability. The term 'prolotherapy' itself is generally attributed to George Stuart Hackett, an American physician who developed and documented injection protocols for ligament and tendon repair during the 1950s. Hackett's work laid an early foundation for the modern practice, and he is often credited with coining the 'prolo' prefix, derived from 'proliferant,' referencing the stimulation of new tissue growth.

The approach evolved further through the contributions of subsequent practitioners in osteopathic and integrative medicine, who refined injection techniques and explored expanded applications. By the late twentieth century, prolotherapy had gained a niche following in sports medicine, pain management, and complementary health circles across North America and parts of Europe.

Historically, the practice has occupied a complicated position — enthusiastically adopted by some clinicians and their patients, yet regarded with skepticism by conventional medical institutions due to limited large-scale research. That dynamic continues today, though growing interest in regenerative medicine has brought renewed attention and research investment to injection-based therapies, of which prolotherapy is considered an earlier predecessor.